- Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates
- Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference
- FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting
- Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
- Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting
- Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
On Friday, Rallybio Corp (RLYB:NSQ) closed at 1.67, 36.33% above the 52 week low of 1.23 set on Feb 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.60 |
---|---|
High | 1.69 |
Low | 1.60 |
Bid | 1.62 |
Offer | 1.70 |
Previous close | 1.59 |
Average volume | 244.82k |
---|---|
Shares outstanding | 41.45m |
Free float | 36.72m |
P/E (TTM) | -- |
Market cap | 69.22m USD |
EPS (TTM) | -1.88 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼